THE INFLUENCE OF HEMERIN ON THE COURSE OF CHRONIC GLOMERULONEPHRITIS
https://doi.org/10.21886/2219-8075-2017-8-3-55-63
Abstract
Objective: determination of the infl uence of hemerin on the features of the course of chronic glomerulonephritis.
Materials and method: the study included 80 patients with chronic glomerulonephritis. Th e criterion for including patients in the study was the presence of indications for nephrobiopsy and the patient’s consent to perform it. All patients underwent general clinical examination with establishment of anamnesis of the disease, creatinine level, urea, calculation of GFR, determination of the general blood test, general urine analysis, daily proteinuria. Venous blood sampling was used to determine the level of hemerin. Twelve months aft er the patients were admitted to the study and treated according to standard therapy, several indicators were re-recorded.
Results: positive correlation associations of hemerin and sedimentation rate of erythrocytes, total cholesterol and negative - with the level of protein in the blood have been established. It was shown that significantly more significant improvement in the clinical manifestations of renal remodeling was observed in patients with a high level of hemerin (≥ 297 pg / ml) 12 months aft er treatment in comparison with the group of patients with lower values of Hemerin (<297 pg / ml) - the hyperhydration Syndrome, the proteinuria of a single and daily portion, total cholesterol, fibrinogen decreased to a greater extent.
Conclusion: based on the presented results of statistical analysis, it is possible to judge the severity of clinical manifestations associated in patients with elevated values of hemerin. However, aft er the standard therapy of chronic glomerulonephritis, these patients have better dynamics in stabilizing clinical parameters. It is possible to assume some protective function of hemerin in patients with glomerulonephritis.
About the Authors
E. S. LevitskayaRussian Federation
Levitskaya Ekaterina Sergeevna— Ph.D., assistant of the Department of Internal Medicine No. 2
A. V. Razina
Russian Federation
Alexandra V. Razina — postgraduate student of the Department of Internal Medicine No. 2, nephrologist at the Nephrology Clinic
M. M. Batiushin
Russian Federation
Mikhail M. Batiushin — MD, Professor of the Department of Internal Medicine No. 2, head of the nephrologic department
E. A. Sinelnik
Russian Federation
Elena A. Sinelnik — Head of the pathoanatomical department of the Regional Hospital No. 2
N. V. Antipova
Russian Federation
Natalia V. Antipova — Head of the nephrologic department of the Regional Hospital No. 2
A. A. Kastanayan
Russian Federation
Aleksandr A. Kastanayan — MD, Professor, Head of the Department of Internal Medicine No. 2, Head of the Therapeutic Department No. 2
B. I. Vorobyov
Russian Federation
Boris I. Vorobyov — MD, Professor of the Department of Internal Medicine No. 2
References
1. Batiushin M.M. Hemerin. Role in the regulation of infl ammation and the possibility of learning in nephrology. Nephrology. 2014;18(5):8-15. (in Russ.) doi: 10.24884/1561-6274-2014-58-15. (In Russ).
2. Salama FE, Anass QA, Abdelrahman AA, Saeed EB. Chemerin: A Biomarker for Cardiovascular Disease in Diabetic Chronic Kidney Disease Patients. Saudi J Kidney Dis Transpl. 2016;27(5):977-984. doi: 10.4103/1319-2442.190867
3. Sell H, Divoux A, Poitou C, Basdevant A, Bouillot J-L et al. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases aft er weight loss induced by bariatric surgery. J. Clin. Endocrinol.Metab. 2010;95(6):2892-2896. doi: 10.1210/jc.2009-2374.
4. Berg V, Sveinbjornsson B, Bendiksen S, Brox J, Meknas K, et al. Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes infl ammatory signalling upon binding the ligand chemerin (21-157). Arthritis Research & Th erapy. 2010;12(6):228. doi: 10.1186/ar3215
5. Skrzeczynska-Moncznik J, Wawro K, Stefanska A, Oleszycka E, Kulig P et al. Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin. Biochem.Biophys. Res. Commun. 2009;380(2):323-327. doi: 10.1016/j.bbrc.2009.01.071.
6. Leiherer A, Muendlein A, Kinz E, Vonbank A, Rein P, et al. High plasma chemerin is associated with renal dysfunction and predictive for cardiovascular events - Insights from phenotype and genotype characterization. Vascular Pharmacology. 2015;77:60-68. doi: 10.1016/j.vph.2015.08.010
7. Pfau D, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M. Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care. 2010;33(1):171173. doi: 10.2337/dc09-1351.
8. Rutkowski P, Sledzinski T, Zielinska H, Lizakowski S, Goyke E, et al.. Decrease of serum chemerin concentration in patients with end stage renal disease aft er successful kidney transplantation. Regul.Pept. 2012;173(1-3):55-59. doi:10.1016/j.regpep.2011.09.005.
9. Yamamoto T, Qureshi AR, Anderstam B, Heimburger O, Barany P, et al. Clinical importance of an elevated circulating chemerin level in incident dialysis patients. Nephrol. Dial. Transplant. 2010;25(12):4017-4023. doi: 10.1093/ndt/gfq329.
10. Batiushin MM, Pasechnik AV, Chistyakov VA. Regulatory role of hemerin in the processes of infl ammation and remodeling.Th e prospects of its study in the pathology of the kidneys. Journal of Fundamental Medicine and Biology. 2013;(4):4-9.(In Russ).
Review
For citations:
Levitskaya E.S., Razina A.V., Batiushin M.M., Sinelnik E.A., Antipova N.V., Kastanayan A.A., Vorobyov B.I. THE INFLUENCE OF HEMERIN ON THE COURSE OF CHRONIC GLOMERULONEPHRITIS. Medical Herald of the South of Russia. 2017;8(3):55-63. (In Russ.) https://doi.org/10.21886/2219-8075-2017-8-3-55-63